Publication Listing for the MeSH term mitomycin C. Found 3 abstracts

Cohen SJ, Dobelbower Jr R, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. International Journal of Radiation Oncology Biology Physics. 2005 Jan;62(5):1345-50.

Odwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines. Biochemical pharmacology. 1996 Jul 12;52(1):21-7.

SutantoWard E, Arisawa Y, Tremiterra S, Sigurdson ER. Regional chemotherapy for colorectal hepatic metastases: Evidence for improved survival with new drug combinations. Annals of Surgical Oncology. 1996 Jan;3(1):36-43.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

mitomycin C carcinoma toxicity cancer chemotherapy Tumors External beam radiotherapy glutathione depletion liver metastases fluorodeoxyuridine 5-fluorouridine pancreas carcinoma buthionine sulfoximine hepatic arterial Adenocarcinoma of the pancreas fluorouracil Diseases cancer staging Oncology DT-diaphorase drug-resistant cisplatin resistance inhibition gene expression Locally advanced glutathione Pancreatic cancer randomized trial Toxicity hepatic metastases floxuridine colon cancer activation rat infusion cancer radiotherapy FUdR Patient treatment ovarian cancer colorectal cancer cells 5-fluorouracil Disease free survival time Radiotherapy reductase Chemotherapy